Matches in Nanopublications for { ?s ?p " TNKase® (Tenecteplase) is indicated for use in the reduction of mortality associated with acute myocardial infarction (AMI) Treatment should be initiated as soon as possible after the onset of AMI symptoms, according to the drug's manufacturer. The drug is available in the US for $1,000 in the U.S. and Europe for $2,000." ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom " TNKase® (Tenecteplase) is indicated for use in the reduction of mortality associated with acute myocardial infarction (AMI) Treatment should be initiated as soon as possible after the onset of AMI symptoms, according to the drug's manufacturer. The drug is available in the US for $1,000 in the U.S. and Europe for $2,000." provenance.